MB, Levis & Associates’s Eli Lilly LLY Stock Holding History

MB, Levis & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$150K	Hold	125	–	–	0.06%	70
2026 Q1	$115K	Hold	125	–	–	0.05%	74
2025 Q4	$135K	Hold	125	–	–	0.06%	68
2025 Q3	$95.5K	Sell	125 -66	-35%	-$49.1K	0.04%	84
2025 Q2	$149K	Buy	191 +29	+18%	+$22.5K	0.07%	74
2025 Q1	$134K	Hold	162	–	–	0.06%	75
2024 Q4	$125K	Sell	162 -4	-2%	-$3.31K	0.06%	77
2024 Q3	$147K	Hold	166	–	–	0.07%	70
2024 Q2	$150K	Hold	166	–	–	0.08%	68
2024 Q1	$129K	Buy	166 +36	+28%	+$25.6K	0.07%	72
2023 Q4	$76.1K	Hold	130	–	–	0.04%	94
2023 Q3	$70K	Hold	130	–	–	0.05%	95
2023 Q2	$61.1K	Hold	130	–	–	0.04%	105
2023 Q1	$44.7K	Hold	130	–	–	0.03%	115
2022 Q4	$47.6K	Buy	+130	New	+$46.1K	0.04%	109

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MB, Levis & Associates's LLY Position: Q2 2026 in Review

MB, Levis & Associates held its Eli Lilly (LLY) position steady in Q2 2026 at 125 shares worth $150K. The position accounts for 0.06% of the portfolio, ranked #70.

MB, Levis & Associates first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

MB, Levis & Associates held 125 shares of Eli Lilly worth $150K as of Q2 2026.
MB, Levis & Associates left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.06% of MB, Levis & Associates's portfolio in Q2 2026, its #70 holding.
MB, Levis & Associates first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.